HALOZYME THERAPEUTICS INC: Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in HALOZYME THERAPEUTICS INC. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
5
13F filers
Aggregate Value
$186.8M
Across holders
Last Price
—
EOD close
Sector
—
GICS
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 66.02M | $96.7M | 51.8% | 0.0% | Added | +$60.0M | Q2 2026 |
| Point72 Asset Management, L.P. CIK 0001603466 | Hedge Fund | 41.35M | $60.5M | 32.4% | 0.1% | Reduced | $-8.8M | Q2 2026 |
| MILLENNIUM MANAGEMENT LLC CIK 0001273087 | Hedge Fund | 18.76M | $27.5M | 14.7% | 0.0% | Reduced | $-14.9M | Q2 2026 |
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 1.00M | $1.5M | 0.8% | 0.0% | Reduced | $-24.6M | Q2 2026 |
| Man Group plc CIK 0001637460 | Hedge Fund | 370K | $541K | 0.3% | 0.0% | Unchanged | +$0 | Q2 2026 |
Added
Hedge Fund
$96.7M· 51.8% of total· 0.0% port· 66.02M sh· +$60.0M QoQ· Q2 2026
Reduced
Hedge Fund
$60.5M· 32.4% of total· 0.1% port· 41.35M sh· $-8.8M QoQ· Q2 2026
Reduced
Hedge Fund
$27.5M· 14.7% of total· 0.0% port· 18.76M sh· $-14.9M QoQ· Q2 2026
Reduced
Hedge Fund
$1.5M· 0.8% of total· 0.0% port· 1.00M sh· $-24.6M QoQ· Q2 2026
Unchanged
Hedge Fund
$541K· 0.3% of total· 0.0% port· 370K sh· +$0 QoQ· Q2 2026